您当前所在的位置:首页 > 产品中心 > 产品详细信息
3056-17-5 分子结构
点击图片或这里关闭

1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

ChemBase编号:531
分子式:C10H12N2O4
平均质量:224.21328
单一同位素质量:224.07970687
SMILES和InChIs

SMILES:
O1[C@@H](n2cc(c(=O)[nH]c2=O)C)C=C[C@H]1CO
Canonical SMILES:
Cc1cn([C@@H]2O[C@@H](C=C2)CO)c(=O)[nH]c1=O
InChI:
InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1
InChIKey:
XNKLLVCARDGLGL-JGVFFNPUSA-N

引用这个纪录

CBID:531 http://www.chembase.cn/molecule-531.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
IUPAC传统名
stavudine
商标名
Zerit
Zerit XR
Zerut XR
别名
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
STV
Estavudina [INN-Spanish]
Sanilvudine
Stavudine [Usan:Ban:Inn]
Stavudinum [INN-Latin]
2',3'-Didehydro-3'-deoxythimidine
3'-Deoxy-2'-thymidinene
stavudine
Stavudine
2',3'-Didehydro-3'-deoxythymidine, 3'-Deoxy-2'-thymidinene
3'-Deoxy-2',3'-didehydrothymidine
Avostav
D4t, BMY-27857, Zerit
NSC 163661
Virostav
Sanilvudine
1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine
2′,3′-Anhydrothymidine
d4T
2′,3′-Didehydro-3′-deoxythymidine
CAS号
3056-17-5
MDL号
MFCD00132921
PubChem SID
46506943
24278356
160963994
PubChem CID
18283

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 9.952853  质子受体
质子供体 LogD (pH = 5.5) -0.23182122 
LogD (pH = 7.4) -0.23300652  Log P -0.2318061 
摩尔折射率 55.3163 cm3 极化性 21.057823 Å3
极化表面积 78.87 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P -0.73  LOG S -0.74 
溶解度 4.05e+01 g/l 

分子性质

分子性质

理化性质 安全信息 产品相关信息 生物活性(PubChem)
溶解度
5-10 g/100 mL at 21 oC expand 查看数据来源
Chloroform expand 查看数据来源
DMSO expand 查看数据来源
Ethanol expand 查看数据来源
Methanol expand 查看数据来源
外观
White to Off-White Solid expand 查看数据来源
熔点
165-166°C expand 查看数据来源
疏水性(logP)
-0.488 expand 查看数据来源
-0.8 expand 查看数据来源
保存条件
-20°C Freezer expand 查看数据来源
RTECS编号
XP2075000 expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
2 expand 查看数据来源
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand 查看数据来源
保存温度
-20°C expand 查看数据来源
纯度
≥98% (TLC) expand 查看数据来源
95% expand 查看数据来源
98% expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
Empirical Formula (Hill Notation)
C10H12N2O4 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Sigma Aldrich Sigma Aldrich TRC TRC
DrugBank -  DB00649 external link
Item Information
Drug Groups approved; investigational
Description A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. [PubChem]
Indication For the treatment of human immunovirus (HIV) infections.
Pharmacology Stavudine is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Stavudine is phosphorylated to active metabolites that compete for incorporation into viral DNA. They inhibit the HIV reverse transcriptase enzyme competitively and act as a chain terminator of DNA synthesis. The lack of a 3'-OH group in the incorporated nucleoside analogue prevents the formation of the 5' to 3' phosphodiester linkage essential for DNA chain elongation, and therefore, the viral DNA growth is terminated.
Toxicity Side effects include peripheral neuropathy tingling, burning, numbness, or pain in the hands or feet), fatal lactic acidosis has been reported in patients treated with stavudine (ZERIT) in combination with other antiretroviral agents, severe liver enlargement, inflammation (pain and swelling) of the liver, and liver failure.
Affected Organisms
Human Immunodeficiency Virus
Biotransformation Phosphorylated intracellularly to stavudine triphosphate, the active substrate for HIV-reverse transcriptase.
Absorption Following oral administration, stavudine is rapidly absorbed (bioavailability is 68-104%).
Half Life 0.8-1.5 hours (in adults)
Protein Binding Negligible
Distribution * 46 ± 21 L
Clearance * Renal cl=272 mL/min [Healthy subjects receiving 80 mg PO]
* 594 +/- 164 mL/min [HIV-infected adult and pediatric patients following 1-hour IV infusion]
* 9.75 +/- 3.76 mL/min/kg [HIV- Exposed or -Infected Pediatric Patients(Age 5 weeks – 15 years) following 1-hour IV infusion]
External Links
Wikipedia
RxList
PDRhealth
Drugs.com
Sigma Aldrich -  D1413 external link
Biochem/physiol Actions
Nucleoside analog which inhibits HIV replication in vitro.
Toronto Research Chemicals -  S685250 external link
Used as an antiviral. A reverse transcriptase inhibitor.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Mansuri, M.M., et al.: Antimicrob. Ag. Chemother., 34, 637 (1990)
  • Cretton, E.M., et al.: Antimicrob. Ag. Chemother., 37, 1816 (1990)
  • Browne, M.J., et al.: J. Infec. Dis., 167, 21 (1993)
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle